Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bay-12-9566: a promising anticancer compound progresses to phase III at Bayer

June 22, 1998

Telomerase inhibitors in early development at CRC

June 22, 1998

Pharmachemie discovers new paclitaxel prodrugs for use in ADEPT

June 19, 1998

Sugen to initiate expanded trials of SU-5416 in U.S. and Europe

June 19, 1998

New fluorinated anthracyclines from M.D. Anderson

June 19, 1998

Neose Technologies and Bristol-Myers Squibb collaborate on oncologic vaccines

June 19, 1998

Elinafide, a potent antitumor agent plagued by significant toxicities

June 19, 1998

Phase I trial results presented for perillyl alcohol

June 19, 1998

Introgen reports results of phase I/II adenoviral-p53 gene therapy trial

June 19, 1998

biosyn Arzneimittel seeks licensees for its oncolytic products

June 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...